Xavier Quilliet
Centre national de la recherche scientifique
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Xavier Quilliet.
Gene Therapy | 1997
Lin Zeng; Xavier Quilliet; Odile Chevallier-Lagente; Eric Eveno; Alain Sarasin; Mauro Mezzina
With the aim to devise a long-term gene therapy protocol for skin cancers in individuals affected by the inherited autosomal recessive xeroderma pigmentosum, we transferred the human DNA repair XPA, XPB/ERCC3 and XPC cDNAs, by using the recombinant retroviral vector LXSN, into primary and immortalized fibroblasts obtained from two XP-A, one XP-B (associated with Cockayne’s syndrome) and two XP-C patients. After transduction, the complete correction of DNA repair deficiency and functional expression of the transgenes were monitored by UV survival, unscheduled DNA synthesis and recovery of RNA synthesis, and Western blots. The results show that the recombinant retroviruses are highly efficient vectors to transfer and stably express the human DNA repair genes in XP cells and correct the defect of DNA repair of group A, B and C. With our previous results with XPD/ERCC2, the present work extends further promising issues for the gene therapy strategy for most patients suffering from this cancer-prone syndrome.
Mutation Research-dna Repair | 1996
Xavier Quilliet; Odile Chevallier-Lagente; Eric Eveno; Tania Stojkovic; Alain Destée; Alain Sarasin; Mauro Mezzina
Due to their limited life time in culture and their relative resistance to DNA transfection, primary fibroblasts derived from UV-hypersensitive patients could not be used for cloning DNA repair gene and studying stable complementation with wild-type DNA repair genes. Primary cells were only used for complementation analysis after transient expression through cell fusion. DNA microinjection and transfection. We report the retroviral-mediated highly efficient transfer and stable expression of XPD/ERCC2 gene in fibroblast strains from eight different patients using the LXPDSN retroviral vector. Cells derived from skin biopsies of xeroderma pigmentosum and trichothiodystrophy patients were incubated with vector-containing suspension and selected with the neomycin-analog G418. LXPDSN vector specifically complemented cells belonging to the XP-D group. Long-term reversion of repair-deficient phenotype, monitored by UV survival and UDS analysis, has been achieved in these diploid fibroblasts. We demonstrate this methodology is a powerful tool to study phenotypic reversion of nucleotide excision repair-deficient cells such as cellular DNA repair properties and we suggest that it may be used to study other cellular parameters (cell cycle regulation, p53 stability or immunosurveillance-controlling factors) involved in UV-induced skin cancers and which reliability requires the use of untransformed cells.
Mutation Research-dna Repair | 1997
Xavier Quilliet; Odile Chevallier-Lagente; Lin Zeng; Régis Calvayrac; Mauro Mezzina; Alain Sarasin; Monique Vuillaume
Xeroderma pigmentosum (XP) is a rare inherited disease associated with photosensitivity, a very high susceptibility to develop neoplasm on sun-exposed skin and neurological abnormalities for some patients. We previously reported that diploid cell lines established from XP skin biopsies present an abnormal low level of catalase activity, which is involved in the defense against oxygen free radicals. This biochemical dysfunction, probably involved in the skin cancer formation, has been difficult to be directly related to the nucleotide excision repair (NER) defect in XP. In this paper we report that the retroviral-mediated transduction of XP diploid cells by the XPC and XPD/ERCC2 cDNAs fully and stably corrects the NER defect in terms of survival and unscheduled DNA synthesis (UDS) after ultraviolet (UV) irradiation. The catalase activity in transduced cells was recovered up to normal levels only in cells transduced with repair genes correcting the repair defect. These results imply that: (i) the reduced catalase activity in XP, which might result from cellular depletion of its NADPH cofactor, is directly related to impaired DNA repair, and (ii) this depletion might be one of the multiple cellular consequences of XP inborn defect.
Biochimie | 1995
E. Eveno; Xavier Quilliet; Odile Chevallier-Lagente; Leela Daya-Grosjean; Anne Stary; L. Zeng; Annie Benoit; E. Savini; G. Ciarrocchi; P. Kannouche; B. Salles; Alain Sarasin; Mauro Mezzina
To characterize nucleotide excision repair properties of cells from trichothiodystrophy (TTD) patients genetically-related to the xeroderma pigmentosum (XP) group D, TTD skin fibroblasts from two unrelated patients (TTD1VI and TTD2VI) belonging to the TTD/XPD group were transformed with a plasmid containing SV40 large T antigen-coding sequences and some DNA repair properties, such as unscheduled DNA synthesis (UDS), UV-survival, in vitro repair synthesis of cell extracts and reactivation of UV-irradiated reporter plasmid were studied. Results showed that: a) both untransformed and transformed TTD cells present a reduced UV-survival, compared to wild-type cells, but at significantly less reduced levels than XP-D cells; b) reduced repair activities were detected in both TTD and XP-D transformed cells by using in vitro cell free extract repair and reactivation of UV-irradiated plasmid procedures, and these relative reduced extents correlated with respective UV-survival; c) surprisingly, near wild-type UDS levels were detected in TTD2VILas transformed cells at different passages after the crisis, suggesting a phenotypic reversion of this transformed cell line; d) fluoro-cytometric analysis of TTD2VILas cells revealed a strong increase of a cell population containing a DNA amount more than twice as high than that of untransformed cells; finally, e) when UDS data were normalized to the DNA content in TTD2VILas cells, it appeared that the repair efficiency was only slightly higher than in untransformed cells. This implies that in transformed cells DNA repair properties should be evaluated, taking into account additional parameters. We obtained an immortalized TTD cell line which maintains DNA repair properties similar to those of parental untransformed cells and may be used to characterize the TTD defect at genetic, molecular and biochemical levels.
Cancer Research | 1995
Eric Eveno; François Bourre; Xavier Quilliet; Odile Chevallier-Lagente; Len Roza; André P. M. Eker; Wim J. Kleijer; Osamu Nikaido; Miria Stefanini; Jan H.J. Hoeijmakers; D. Bootsma; James E. Cleaver; Alain Sarasin; Mauro Mezzina
Proceedings of the National Academy of Sciences of the United States of America | 1997
Constanze Ahrens; Markus Grewe; Mark Berneburg; Susanne Grether-Beck; Xavier Quilliet; Mauro Mezzina; Alain Sarasin; Alan R. Lehmann; C.F. Arlett; Jean Krutmann
Human Gene Therapy | 1995
Madeleine Carreau; Xavier Quilliet; Eric Eveno; Anna Salvetti; Olivier Danos; Jean-Michel Heard; Mauro Mezzina; Alain Sarasin
Carcinogenesis | 1995
Madeleine Carreau; Eric Eveno; Xavier Quilliet; Odile Chevalier-Lagente; Annie Benoit; Bianca Tanganelli; Miria Stefanini; Wim Vermeulen; Jan H.J. Hoeijmakers; Alian Sarasin; Mauro Mezzina
Carcinogenesis | 1998
Nicolas Dumaz; Christiane Drougard; Xavier Quilliet; Mauro Mezzina; Alain Sarasin; Leela Daya-Grosjean
Cancer Research | 1996
Claire Marionnet; Xavier Quilliet; Annie Benoit; Jacques Armier; Alain Sarasin; Anne Stary